The CCK-8 assay provided evidence for MARK3 overexpression and inhibited the proliferation of endometrial cancer cells, demonstrating a significant decrease in the proliferation rate of MARK3-overexpressing cells relative to control groups. The gene discussed is MARK3; the disease is endometrial cancer.